1-4 of 4
Reza Mehran
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Evolution of Genomic and T-cell Repertoire Heterogeneity of Malignant Pleural Mesothelioma Under Dasatinib Treatment

Runzhe Chen, Won-Chul Lee, Junya Fujimoto, Jun Li, Xin Hu, Reza Mehran, David Rice, Stephen G. Swisher, Boris Sepesi, Hai T. Tran, Chi-Wan Chow, Latasha D. Little, Curtis Gumbs, Cara Haymaker, John V. Heymach, Ignacio I. Wistuba, J. Jack Lee, P. Andrew Futreal, Jianhua Zhang, Alexandre Reuben, Anne S. Tsao, Jianjun Zhang
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (20): 5477–5486.
https://doi.org/10.1158/1078-0432.CCR-20-1767
Published: 15 October 2020
View article titled, Evolution of Genomic and T-cell Repertoire Heterogeneity of Malignant Pleural Mesothelioma Under Dasatinib Treatment
Open the PDF for Evolution of Genomic and T-cell Repertoire Heterogeneity of Malignant Pleural Mesothelioma Under Dasatinib Treatment in another window
Includes: Supplementary data
Journal Articles

A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 Analogue Peptide Vaccine, After Multimodality Therapy for Patients with Malignant Pleural Mesothelioma

Marjorie G. Zauderer, Anne S. Tsao, Tao Dao, Katherine Panageas, W. Victoria Lai, Andreas Rimner, Valerie W. Rusch, Prasad S. Adusumilli, Michelle S. Ginsberg, Daniel Gomez, David Rice, Reza Mehran, David A. Scheinberg, Lee M. Krug
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (24): 7483–7489.
https://doi.org/10.1158/1078-0432.CCR-17-2169
Published: 14 December 2017
View article titled, A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 Analogue Peptide Vaccine, After Multimodality Therapy for Patients with Malignant Pleural Mesothelioma
Open the PDF for A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 Analogue Peptide Vaccine, After Multimodality Therapy for Patients with Malignant Pleural Mesothelioma in another window
Includes: Supplementary data
Journal Articles

Abstract B37: Investigating the potential of miR-203 as a therapeutic candidate and its role in the pathobiology of malignant pleural mesothelioma (MPM)

Milind Suraokar, Kevin Coombes, Anne Tsao, Ignacio Wistuba, Yi Zhang, Chi-wan Chow, David Kim, Lixia Diao, Junya Fujimoto, Reza Mehran, Jin Wang, Carmen Behrens
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (3_Supplement): B37.
https://doi.org/10.1158/1078-0432.12AACRIASLC-B37
Published: 01 February 2012
View article titled, Abstract B37: Investigating the potential of miR-203 as a therapeutic candidate and its role in the pathobiology of malignant pleural mesothelioma (MPM)
Open the PDF for Abstract B37: Investigating the potential of miR-203 as a therapeutic candidate and its role in the pathobiology of malignant pleural mesothelioma (MPM) in another window
Journal Articles

Expression of Interleukin-1 Receptor–Associated Kinase-1 in Non–Small Cell Lung Carcinoma and Preneoplastic Lesions

Carmen Behrens, Lei Feng, Humam Kadara, Hyun-Jung Kim, J. Jack Lee, Reza Mehran, Waun Ki Hong, Reuben Lotan, Ignacio I. Wistuba
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (1): 34–44.
https://doi.org/10.1158/1078-0432.CCR-09-0650
Published: 04 January 2010
View article titled, Expression of Interleukin-1 Receptor–Associated Kinase-1 in Non–Small Cell Lung Carcinoma and Preneoplastic Lesions
Open the PDF for Expression of Interleukin-1 Receptor–Associated Kinase-1 in Non–Small Cell Lung Carcinoma and Preneoplastic Lesions in another window
Includes: Supplementary data